A pre-clinical vaccine candidate targeting the dangerous synthetic opioid fentanyl (FEN) was recently found to block its ability to enter the brain, thus eliminating the drug's "high."
The breakthrough discovery by researchers led by the University of Houston could have significant implications for the nation's opioid epidemic by becoming a relapse prevention agent for people trying to quit using opioids.
While research reveals Opioid Use Disorder (OUD) is treatable, an estimated 80% of those dependent on the drug suffer a relapse.
-
-
COVID-19 Pandemic Challenges Osteoporosis Management
-
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
-
Survival From COVID-19 High in Patients With Psoriasis
-
FDA Needs More Safety Data on COVID-19 Vaccines, Experts Say
